Atefeh Rayatpour

Biography

I grew up in Iran and moved to Calgary in June 2023 to continue my research journey. In the lab, I’m passionate about research and love digging into experimental questions that connect basic science to real‑world impact. Outside of work, you can usually find me cooking (people insist I’m a good cook, and I don’t argue), reading, watching science‑fiction movies, or playing ping pong. I’m not a professional photographer, but whenever I’m out in nature I end up taking a lot of photos, my gallery has grown to more than 19,000 pictures.

Publications

1. Rayatpour A, Foolad F, and Javan M. Deferiprone promoted remyelination and functional recovery through enhancement of oligodendrogenesis in experimental demyelination animal model. Naunyn-Schmiedeberg’s Archives of Pharmacology. 2024.
2. Mokhtarzadeh A, Rayatpour A, Baharvand H, and Javan M. Neuroglial components of brain lesions may provide new therapeutic strategies for multiple sclerosis. Neurological Sciences. 2023.
3. Rayatpour A, Foolad F, Heibatollahi M, Khajeh Kh, and Javan M. Ferroptosis inhibition by deferiprone attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve. Scientific Reports. 12:19630. 2022.
4. Rayatpour A, Farhangi S, Verdaguer E, Olloquequi J, Ureña J, Auladell C, and Javan M. The cross talk between underlying mechanisms of multiple sclerosis and epilepsy may provide new insights for more efficient therapies. Pharmaceuticals. 2021.
5. Rayatpour A, and Javan M. Targeting the brain lesions using peptides: a review focused on the possibility of targeted drug delivery to multiple sclerosis lesions. Pharmacological Research. 2021.

Awards

• MS Canada Postdoctoral Fellowship, MS Canada. 2024-2027.
• Harley Hotchkiss-Samuel Weiss Postdoctoral Fellowship, Hotchkiss Brain Institute, University of Calgary. 2024-2027.
• Cumming School of Medicine Postdoctoral Fellowship, University of Calgary. 2024-2027.